Cited by 111Mental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychosomatic Disorders and Their Treatments

Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study.

Open access
Uhlenbusch, Natalie, Löwe, Bernd, Härter, Martin, Schramm, Christoph, Weiler-Normann, Christina, Depping, Miriam K.·2019·PLoS ONE

Abstract

OBJECTIVE: Empirical evidence on depression and anxiety in patients with rare diseases is scarce but can help improve comprehensive treatment. The objectives of this study were to investigate the frequency of depression and anxiety in this heterogeneous population and to examine aspects associated with increased psychopathology. METHODS: N = 300 patients with 79 different rare diseases (female:80%, age:M = 44.3(12.8), range:16-74 years) participated in a cross-sectional online study. We determined the percentages of patients reporting elevated depression (PHQ-9) and anxiety (GAD-7) scores. We calculated two linear regressions with depression and anxiety as outcomes. Predictor variables were diagnosis-related aspects (diagnosis assigned to ICD-10 chapter, visibility of symptoms, time since diagnosis, comorbid diseases), perceived somatic-symptom-severity (PHQ-15), illness-perceptions (consequences, control, identity, concern, understanding and treatment control; B-IPQ-R), coping mechanisms (constructive attitudes, active engagement in life) and social support (heiQ). We controlled for gender, age and depression or anxiety depending on the outcome. RESULTS: 42% of the patients (95%CI [36.41%,47.59%]) reported depression scores indicating moderately or severely elevated symptom levels. Regarding anxiety, this applies to 23% (95%CI [18.54%,28.06%]). Variables significantly associated with depression were higher perceived somatic-symptom-severity (B = 0.41,p < .001), less control (B = .17,p < .05), lower levels of concern (B = -0.32,p < .01) and less constructive attitudes (B = -1.40,p < .001). No diagnosis-related variables were associated with depression. Variables significantly associated with anxiety were diseases of the circulatory system compared to congenital malformations (B = 1.88,p < .05), less consequences (B = -0.32,p < .05) and more concern (B = -0.32,p < .01). CONCLUSION: The data reveal first insights into depression and anxiety in patients with different rare diseases. High percentages of patients showed clinically relevant symptom burden. No diagnosis-related differences were found in depression while anxiety seems to be particularly frequent in patients with rare diseases of the circulatory system. Besides perceived somatic symptom severity, cognitive appraisal seems to be linked to depression. Supporting patients in coping with their disease may help reduce psychopathology and therefore improve overall health.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0211343

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Youths with chronic medical conditions represent a high-risk group for comorbid anxiety, depression, or behavioral problems, with a reported prevalence of 10% to 42%.

    “Youths with chronic medical conditions (CMCs) represent a high-risk group for comorbid anxiety, depression, or behavioral problems, with a reported prevalence of 10% to 42%.1,2,3,4,5,6”

    From Efficacy of Motivational Interviewing to Improve Utilization of Mental Health Services Among Youths With Chronic Medical Conditions: A Cluster Randomized Clinical Trial (2021) · cites this paper as [1]

    The Results (Symptoms of depression and anxiety; no page provided) report elevated depression symptoms in 42% of participants and anxiety symptoms in 23%, supporting part of the claim. But the sample had a mean age of 44.3 years (Results, Preliminary analyses), and the paper does not establish a 10%–42% prevalence range or assess behavioral problems in youths. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [21]Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002; 32(9): 509– 15.
  2. [32]Gräfe K, Zipfel S, Herzog W, Löwe B. Gesundheitsfragebogen für Patienten (PHQ-D). Ergebnisse der deutschen Validierungsstudie. [Screening for psychiatric disorders with the Patient Health Questionnaire (PHQ). Results from the German validation study.]. Diagnostica. 2004; 50(4): 171– 81.

Cited by

Sorted by citations

Authors
Uhlenbusch, N., Löwe, B., Härter, M., Schramm, C., Weiler-Normann, C., & Depping, M. K.
Affiliations
University Medical Center Hamburg-Eppendorf (DE)
Corresponding author
Uhlenbusch, Natalie
Venue
PLoS ONE
Published
2019-02-20
Volume
14
Issue
2
Pages
e0211343
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2915720434
Cited by
111
References
48
Citations by year
2026: 5 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 10 · 2021: 18 · 2020: 11 · 2019: 6
FWCI
14.14
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Robert Bosch Stiftung
Topics
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
depression, anxiety, rare diseases, chronic disease, psychopathology, illness perception, coping strategies, social support, somatic symptom severity, circulatory diseases, congenital malformations, comorbidities, time since diagnosis, PHQ-9, GAD-7, quality of life, patient mental health
MeSH terms
Adolescent, Adult, Aged, Anxiety, Chronic Disease, Cross-Sectional Studies, Depression, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Severity of Illness Index, Linear Models, Internet, Rare Diseases, Young Adult, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review